Corinne Hedgley

Predictive value of early molecular response in patients with chronic myeloid leukemia treated with first-line dasatinib

David Marín, Corinne Hedgley, Richard E. Clark et al. · Blood · 2012 · 132 citations · Full text

Medicine, Hematology, Oncology +12

Atovaquone-Proguanil versus Chloroquine-Proguanil for Malaria Prophylaxis in Nonimmune Pediatric Travelers: Results of an International, Randomized, Open-Label Study

D. Camus, Félix Djossou, Herbert Schilthuis et al. · Clinical Infectious Diseases · 2004 · 58 citations · Full text

Medicine, Infectious Diseases, Pediatrics +14

KIR2DS1 genotype predicts for complete cytogenetic response and survival in newly diagnosed chronic myeloid leukemia patients treated with imatinib

David Marín, Ian H Gabriel, Sohail Ahmad et al. · Leukemia · 2011 · 52 citations

Life Sciences, Genetics, Oncology +12

A common novel splice variant of <i><scp>SLC</scp>22<scp>A</scp>1</i> (<i><scp>OCT</scp>1)</i> is associated with impaired responses to imatinib in patients with chronic myeloid leukaemia

Jacob Grinfeld, Gareth Gerrard, Mary Alikian et al. · British Journal of Haematology · 2013 · 38 citations

Medicine, Hematology, Molecular Genetics +13

Spirit 2: An NCRI Randomised Study Comparing Dasatinib with Imatinib in Patients with Newly Diagnosed CML

Stephen G. O’Brien, Corinne Hedgley, Sarah Adams et al. · Blood · 2014 · 25 citations

Medicine, Oncology, Pharmacotherapy +4